本周2只新股申购,强一股份、恒运昌等4家公司将上会
Cai Jing Wang·2025-11-11 01:08

IPO Review and Registration Progress - Five companies passed the IPO review last week, including ZhiXin Co. and Shaanxi Tourism, marking the first cultural tourism IPO approval in five years [3][4] - Shaanxi Tourism's IPO aims to raise 1.555 billion yuan for projects like cableway upgrades and performance expansion, with major revenue sources from its performance "Chang Hen Ge" and cableway business [3] - ZhiXin Co. focuses on automotive welding parts and related molds, with concerns raised about market competition and revenue sustainability [4] - Three companies, including QiLong Ocean and HaiSheng Medical, passed the review at the Beijing Stock Exchange, with inquiries focused on financial information authenticity and customer stability [5] Upcoming IPOs - Four companies are set to undergo IPO reviews this week, including QiangYi Co. and HengYunChang, with QiangYi aiming to raise 1.5 billion yuan for semiconductor probe card projects [6] - Financial data for QiangYi shows steady revenue growth from 254 million yuan in 2022 to an estimated 647 million yuan in 2025, but highlights high customer concentration risks [6][7] - HengYunChang plans to raise 1.469 billion yuan, but anticipates a revenue decline in 2025 due to increased R&D expenses and capacity expansion costs [7] New Stock Listings - Five new stocks were listed last week, with DanNa Bio experiencing a significant increase of 497.08% on its first day [14][15] - Other notable listings include FengBei Bio and DaMing Electronics, with respective first-day gains of 172.6% and 413.55% [14][15] - This week, two new stocks are scheduled for subscription, including NanTe Technology, which aims to raise funds for precision mechanical components [16][17] IPO Applications and Terminations - Two IPO applications were accepted last week, including JiaDeLi and Core Medical, with JiaDeLi seeking to raise 725 million yuan for a new materials production base [10][11] - Core Medical has developed several artificial heart products but has yet to achieve profitability, with significant losses reported [11][12] - Two IPO applications were terminated, including HaiChuang Optoelectronics and JianNeng Technology, due to voluntary withdrawal [13]